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OBJECTIVES We sought to test whether isolated mitral annular (MA) dilation can cause important
functional mitral regurgitation (MR).
BACKGROUND Mitral annular dilation has been considered a primary cause of functional MR. Patients with
functional MR, however, usually have both MA dilation and left ventricular (LV) dilation and
dysfunction. Lone atrial fibrillation (AF) can potentially cause isolated MA dilation, offering
a unique opportunity to relate MA dilation to leaflet function.
METHODS Mid-systolic MA area, MR fraction, LV volumes and papillary muscle (PM) leaflet tethering
length were compared by echocardiography among 18 control subjects, 25 patients with lone
AF and 24 patients with idiopathic or ischemic cardiomyopathy (ICM).
RESULTS Patients with lone AF had a normal LV size and function, but MA dilation (isolated MA
dilation) significant and comparable to that of patients with ICM (MA area: 8.0  1.2 vs.
11.6  2.3 vs. 12.5  2.9 cm2 [control vs. lone AF vs. ICM]; p  0.001 for both lone AF
and ICM). However, patients with lone AF had only modest MR, compared with that of
patients with ICM (MR fraction: 3  8% vs. 3  9% vs. 36  25%; p  0.001 for patients
with ICM). Multivariate analysis identified PM tethering length, not MA dilation, as an
independent primary contributor to MR.
CONCLUSIONS Isolated annular dilation does not usually cause moderate or severe MR. Important functional
MR also depends on LV dilation and dysfunction, leading to an altered force balance on the
leaflets, which impairs coaptation. (J Am Coll Cardiol 2002;39:1651–6) © 2002 by the
American College of Cardiology Foundation
Functional mitral regurgitation (MR) is an important com-
plication that adversely affects the patient’s prognosis (1–6).
Mitral annular (MA) dilation has been postulated as the
main cause of functional MR (7,8); however, it is still
controversial, because patients with functional MR usually
also have left ventricular (LV) dilation and dysfunction,
which have also been assumed as major causes of functional
MR (8–21). Left ventricular dilation has been shown to
cause functional MR by inducing apical displacement of the
leaflets (i.e., incomplete mitral leaflet closure [IMLC], due
to an augmented tethering force by outward displacement of
the papillary muscles (PMs) (8–18). Left ventricular dys-
function has also been shown to cause IMLC and MR by
decreasing the ventricular force needed to close the leaflets
(8,19–21).
Current surgical techniques mainly focus on MA size
reduction (22,23). The results are not always ideal, with
occasional cases of persistent, significant MR, despite a
normal MA size after ring implantation (21,22). Therefore,
to understand the mechanism of functional MR, as well as
to establish its practical or surgical treatment, it is necessary
to isolate the effects of MA dilation from other factors,
especially LV dilation and dysfunction.
Lone atrial fibrillation (AF), known to cause left atrial
dilation without LV dilation and dysfunction (24), can
potentially cause isolated MA dilation. Therefore, patients
with lone AF may offer a unique opportunity to evaluate the
effects of isolated MA dilation on leaflet function. Thus, the
purpose of this study was to test whether isolated MA dilation
can cause important functional MR, by comparing the mitral
complex geometry and MR between patients with lone AF and
potentially isolated MA dilation and those with idiopathic or
ischemic cardiomyopathy (ICM) with combined MA dilation
and LV dilation and dysfunction (7).
METHODS
Study patients. There were 25 consecutive patients with
lone AF and 24 patients with ICM referred for echocardio-
graphic examination from April to December 1999 (Table
1). Eighteen subjects with normal echocardiograms and no
known cardiovascular disease served as the control subjects.
Lone AF was diagnosed on the basis of electrocardiographic
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evidence of AF without LV or right ventricular dilation and
dysfunction, pericardial disease or organic valve lesions on
two-dimensional echo. Idiopathic or ischemic cardiomyop-
athy was diagnosed on the basis of LV dysfunction with an
ejection fraction (EF) 40%, without predominant seg-
mental wall motion abnormalities or organic valve lesions on
two-dimensional echo. Of the 24 patients with ICM, coronary
angiography confirmed that there were no significant stenosis
in 14 and severe lesions in 7 (angiography was not performed
in 3). This study was performed with patients’ written, in-
formed consent, and the institutional committee of Kagoshima
University approved the study protocol.
Echocardiography. Standard two-dimensional and Dopp-
ler echo with color flow mapping were performed using a 2-
to 3-MHz transducer and phased-array sector scanners
(ATL HDI 3000 [Bothell, Washington], Toshiba SSH
380A [Tokyo, Japan], and Hewlett-Packard Sonos 5500
[Andover, Massachusetts]). Recordings of the apical four-
and two-chamber views were done with special attention to
visualize the PM tips. The LV volumes and EF were
obtained by the modified biplane Simpson’s method (25).
Left ventricular sphericity was estimated by the LV short-
to long-axis dimension ratio in the end-systolic apical
four-chamber view (Fig. 1) (26). The mid-systolic MA area
was obtained from its dimensions in the apical four- and
two-chamber views, using an ellipsoid assumption: MA
area d1 d2 /4 (Fig. 1) (27). The MA was identified
as the leaflet hinge points. The end-diastolic, end-systolic
and mid-systolic frames were determined as the initial, last
and middle frame, with systolic mitral leaflet closure,
respectively. To evaluate the apical displacement of the
mitral leaflets, the IMLC area between the leaflets and the
line connecting the annular points was traced at mid-systole
(Fig. 1) (10,15). The leaflet tethering lengths between the
PM tips and the contralateral anterior MA were also
measured in the apical four- and two-chamber views (Fig. 1:
Abbreviations and Acronyms
AF  atrial fibrillation
EF  ejection fraction
ICM  idiopathic or ischemic cardiomyopathy
IMLC  incomplete mitral leaflet closure
LV  left ventricle or ventricular
MA  mitral annulus or annular
MR  mitral regurgitation
PM  papillary muscle
Table 1. Patients’ Characteristics and Echocardiographic Measurements
Control
Group
Lone AF
Group
ICM
Group
p Value by
ANOVA
Age (years) 48  18 69  9* 55  14‡ 0.0001
Male/female (n) 11/7 17/8 22/2 N/A
HR (beats/min) 70  8 82  19 79  19 NS
SBP (mm Hg) 131  24 129  10 105  21‡ 0.001
LVEDV (ml) 87  15 77  22 224  81*‡ 0.001
LVESV (ml) 35  9 33  11 165  76*‡ 0.001
LVEF (%) 60  6 57  7 27  9*‡ 0.001
LV D/L 0.54  0.03 0.50  0.05 0.62  0.07*‡ 0.001
MA area (cm2) 8.0  1.2 11.6  2.3* 12.5  2.9* 0.001
Proximal MR jet cross-sectional
area (cm2)
0.0  0.0 0.05  0.07 0.9  1.1*‡ 0.001
PM tethering length (mm)
Anterior 33.2  2.6 33.4  2.3 44.9  7.1*‡ 0.001
Posterior 33.2  2.4 33.9  2.7 45.1  5.2*‡ 0.001
Sum 66.4  4.5 67.4  3.6 90.0  11.6*‡ 0.001
IMLC area (cm2) 0.07  0.06 0.05  0.10 1.7  0.9*‡ 0.001
MR stroke volume (ml) 2  5 2  5 29  29*‡ 0.001
MR fraction (%) 3  8 3  9 36  25*‡ 0.001
Incidence of moderate to severe MR 0/18 0/25 9/24†§ N/A
*p  0.01 versus control group. †p  0.05 versus control group. ‡p  0.01 versus lone AF group. §p  0.05 versus lone AF
group. Data are presented as the mean value  SD.
AF  atrial fibrillation; ANOVA  analysis of variance; HR  heart rate; ICM  idiopathic or ischemic cardiomyopathy;
IMLC  incomplete mitral leaflet closure; LV D/L  left ventricular short- to long-axis dimension ratio; LVEDV  left
ventricular end-diastolic volume; LVEF  left ventricular ejection fraction; LVESV  left ventricular end-systolic volume;
MA  mitral annulus; MR  mitral regurgitation; PM  papillary muscle; SBP  systolic blood pressure.
Figure 1. Methods to quantitate the geometry of the mitral valve apparatus
and left ventricle (LV) shape. D  short-axis dimension of LV; L 
long-axis dimension of LV; LA  left atrium; RA  right atrium; RV 
right ventricle.
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1 and 2) to estimate displacement of the PM (15–18).
When the PM had multiple heads, the leaflet tethering
length was measured to each head and averaged. The
severity of MR was quantified by Doppler echocardiogra-
phy. The MR stroke volume was obtained as the mitral
filling stroke volume minus the aortic ejection stroke volume
(28–30). The mitral filling and aortic ejection stroke vol-
umes were determined as the time velocity integral of mitral
filling or aortic ejection flow velocity at the annular level,
multiplied by the annular area (28,30). Regurgitant fraction
was calculated as follows: MR fraction (%)  (MR stroke
volume/mitral filling stroke volume) 100. Grading of MR
was done as follows: trace/none  MR fraction 30%;
mild  30% to 40% MR fraction; moderate  40% to
50% MR fraction; severe50% MR fraction (28). The
proximal MR jet cross-sectional area was measured by color
Doppler imaging from the apical four- and two-chamber
view diameters (elliptical area    diameter1  diame-
ter2/4) (31).
Reproducibility of measurements. Two independent ob-
servers repeated 10 measurements of the MA area and PM
tethering length. The differences in the measurements by
the two observers were obtained to estimate interobserver
variability. The same observer repeated the 10 measure-
ments, and intraobserver variability was calculated.
Statistical analysis. Results are expressed as the mean
value  SD. Variables were compared between the three
groups by analysis of variance; if significant, the differences
between the groups were explored using the unpaired
Student t test. Incidences in the groups were tested for
statistical significance using the chi-square test. Determi-
nants of IMLC area and MR fraction were explored by
univariate and stepwise multiple linear regression analyses,
using end-diastolic and end-systolic LV volumes, EF,
sphericity, MA area, PM tethering length and systolic blood
pressure as variables. We calculated adjusted p values by the
Holm-Sidak procedure to avoid the effects of multiple
comparison tests (32). A p value 0.05 was considered
statistically significant.
RESULTS
Comparison of basic measurements between patients
with lone AF and ICM (Table 1). Patients with lone AF
had normal LV volumes and EF, whereas patients with
ICM had significantly abnormal LV volumes and EF. In
contrast, patients with lone AF had MA dilation significant
and comparable to that of patients with ICM. Thus,
patients with lone AF had isolated MA dilation with no LV
dilation or dysfunction. Leaflet tethering lengths of both
PMs were also not increased in patients with lone AF as
compared with patients with ICM.
Mitral regurgitation and IMLC. Patients with lone AF
had a normal IMLC area, whereas the area was significantly
increased in patients with ICM (Table 1). The MR fraction
was also not significantly increased in patients with lone AF,
despite their isolated but significant MA dilation. In con-
trast, the MR fraction was markedly increased in patients
with ICM who had a comparable MA size. Consequently,
moderate to severe MR was observed in none of the patients
with lone AF, although the incidence of such MR was
significantly higher in those with ICM (38%, p  0.05).
Figure 2 shows representative patients. Despite comparable
MA dilation, these patients had prominent differences in
IMLC and MR. The patient with lone AF had a normal
PM tethering length with no significant IMLC and MR; in
contrast, the patient with ICM had a longer tethering
length and significant IMLC and MR.
Determinants of IMLC area and MR fraction. All of the
end-diastolic and end-systolic LV volumes, EF, LV sphe-
ricity, MA areas and PM tethering lengths were significant
determinants of the IMLC area by univariate analysis. The
correlation between the MA area and IMLC area was
relatively weak (r2  0.28), and the MA area was not an
Figure 2. Lack of important incomplete mitral leaflet closure (IMLC) and mitral regurgitation (MR) in a patient with lone atrial fibrillation (AF), despite
annular dilation (yellow arrows), compared with a patient with idiopathic or ischemic cardiomyopathy (ICM) showing moderate IMLC and MR. Longer
papillary muscle tethering length (white arrows) in the patient with ICM restricts leaflet closure and induces IMLC and MR.
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independent determinant of the IMLC area by multivariate
analysis. Figure 3 (left upper panel) shows that patients
with lone AF did not develop significant IMLC with MA
dilation, whereas those with ICM frequently developed
significant IMLC with comparable MA sizes. In con-
trast, the correlation between the IMLC area and PM
tethering length (r2  0.82) was better, and multiple
regression analysis identified increased PM tethering
length, primarily, and increased LV end-systolic volume
for the IMLC area as independent contributors (r2 
0.85). Figure 3 (right upper panel) shows that patients
with lone AF had normal tethering lengths, with no
significant increase in the IMLC area, whereas patients with
ICM had greater tethering lengths, with a significant
increase in the IMLC area.
Similarly, all of the end-diastolic and end-systolic LV
volumes, EF, LV sphericity, MA areas and the PM teth-
ering lengths were significant determinants of MR fraction
by univariate analysis. The correlation between MA area
and MR fraction was also relatively weak (r2  0.33), and
the MA area was not an independent determinant of MR
fraction by multivariate analysis. Figure 3 (left lower panel)
shows that patients with lone AF did not develop moderate
or severe MR with MA dilation, whereas patients with
ICM frequently developed such MR with comparable MA
sizes. In contrast, the correlation between MR fraction and
PM tethering length (r2  0.65) was better, and multivar-
iate analysis identified increased PM tethering length as the
only independent determinant of MR fraction. Figure 3
(right lower panel) shows that patients with lone AF had
normal tethering lengths, with no moderate to severe MR;
in contrast, patients with ICM had greater tethering
lengths, with frequent, important MR.
Reproducibility of measurements. The interobserver and
intraobserver variabilities for the measurements of MA area
were 0.6  0.4 and 0.3  0.2 cm2 or 5.5  3.4% and 2.5 
1.5% of the mean value, respectively. The interobserver and
intraobserver variabilities for the measurements of PM
tethering length were 1.5 1.3 and 0.6 0.2 mm or 4.0
3.4% and 2.4  0.8% of the mean value, respectively.
Figure 3. Scatterplots showing correlations between the incomplete mitral leaflet closure (IMLC) area (upper panels) or percent mitral regurgitation (MR)
fraction (lower panels) and the mitral annular area or sum of the papillary muscle (PM) tethering distance.
1654 Otsuji et al. JACC Vol. 39, No. 10, 2002
Functional Mitral Regurgitation May 15, 2002:1651–6
DISCUSSION
Effects of isolated MA dilation on mitral valve function.
This study demonstrated that isolated MA dilation in
patients with lone AF does not usually cause moderate to
severe MR, even though they have MA dilation comparable
to those with ICM and frequent, significant MR. Patients
with ICM also have 1) LV dilation to augment the
tethering force and restrict leaflet closure; and 2) LV
dysfunction, reducing the ventricular force to close the
leaflets. These results strongly suggest that significant MR
depends on additional LV dilation and dysfunction, which
alter the force balance on the leaflets and create IMLC,
thereby requiring more of the leaflet area to cover the
annulus and exhausting the physiologic surface area of
leaflet coaptation (8–21). However, these results do not
indicate that MA dilation is not important in functional
MR. This study also showed a significant correlation be-
tween MR fraction and MA area (Fig. 3). In addition, MA
size reduction is not always, but usually, effective in elimi-
nating functional MR (22,23). Significant worsening of MR
by addition of MA dilation to PM displacement was also
observed in vitro (8). Therefore, although MA dilation may
not be the strongest determinant of functional MR, it is an
important factor (7,8).
Previous studies. Numerous investigations support the
leaflet tethering hypothesis, with an important role of LV
dilation in the mechanism of functional MR (8–18). Left
ventricular contractile dysfunction has also been proposed as
a significant determinant of functional MR (8,19–21). In
addition, a considerable overlap in MA size between pa-
tients with and those without functional MR has been
reported (33), suggesting that factors other than MA
dilation must also be important in the mechanism of MR.
Therefore, the results of this study are consistent with these
previous, important contributions. However, this study
further emphasizes the importance of LV factors by dem-
onstrating that only modest MR can be induced by isolated
MA dilation, without LV dilation and dysfunction.
Clinical implications. The current study indicates that LV
dilation and dysfunction, in addition to MA dilation, play a
central role in the development of important functional
MR. Therefore, the results can help explain persistent MR
after ring implantation (21,22). Such persistent MR sug-
gests that maintained leaflet tethering and poor LV con-
traction, even with a normal MA size, can potentially cause
significant MR. Therefore, the results suggest the need for
interventions other than normalizing MA size, to repair
functional ischemic MR consistently. Such maneuvers may
include a further reduction in MA size beyond its normal
range (23), infarct reduction to lessen leaflet tethering
(17,22), leaflet or chordal elongation to permit better
coaptation (34) and revascularization to reduce LV size. The
results also suggest the potential benefit of early revascular-
ization or angiotensin-converting enzyme inhibitors to re-
duce or prevent ischemic MR with acute myocardial infarc-
tion (35,36).
Study limitations. This investigation was designed to an-
alyze data obtained by routine clinical echo studies. Esti-
mation of geometric change in the mitral apparatus was
done by two-dimensional echo. Therefore, we could not
evaluate the three-dimensional geometry of the mitral
apparatus by placing a consistent reference point in the
heart, as in previous three-dimensional studies (15–17).
However, outward PM displacement was estimated with
two-dimensional echo by measuring the length between the
PM tip and the contralateral anterior MA, which was
closely correlated to the IMLC area and MR fraction. Yiu
et al. (18) also showed a good correlation between the
two-dimensional echo tethering distance and the severity of
ischemic MR. These data support the adequacy of two-
dimensional echo to provide a measure of tethering length
(16,18).
The mechanism of functional MR may be heterogeneous.
Patients and animal models with functional or ischemic
MR, occasionally demonstrate mitral valve prolapse instead
of IMLC (4,9,37). In this case, the MR cannot be explained
by augmented leaflet tethering, but may relate to PM
elongation (9,38). In addition to MA size, its three-
dimensional shape and motion have also been shown to be
important causes of MR (18,39); however, these analyses
were not done. Other undefined variables, such as leaflet
clefts or fetal commissural cusps, might also worsen MR
when other primary abnormalities are present. We com-
pared patients with isolated MA dilation to patients with
combined MA dilation and LV dilation and dysfunction, so
we could not separate effects of LV dilation from those of
LV dysfunction, which will require further investigation
(15,16).
Conclusions. Although annular dilation can augment
functional MR, isolated annular dilation in patients with
lone AF does not usually cause moderate or severe MR.
Important functional MR also requires LV dilation and
dysfunction, leading to an altered force balance on the
leaflets and IMLC, with the potential for a reduced surface
area of leaflet coaptation.
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